Browsing byAuthorOng, HX

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 15 to 22 of 22< previous 
Issue DateTitleAuthor(s)
2022-02-22Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.Zhang, Y; Almazi, JG; Ong, HX; Johansen, MD; Ledger, S; Traini, D; Hansbro, PM; Kelleher, AD; Ahlenstiel, CL
2014-01Optimization of RPMI 2650 Cells as a Model for Nasal MucosaPozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D
2020-08-21Properties of rapamycin solid lipid nanoparticles for lymphatic access through the lungs & part I: the effect of size.Landh, E; M Moir, L; Bradbury, P; Traini, D; M Young, P; Ong, HX
2021-06Real-time quantitative monitoring of in vitro nasal drug delivery by a nasal epithelial mucosa-on-a-chip model.Gholizadeh, H; Ong, HX; Bradbury, P; Kourmatzis, A; Traini, D; Young, P; Li, M; Cheng, S
2018-08-01Repurposing of statins via inhalation to treat lung inflammatory conditionsBradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX
2020-01-02A review of respiratory anatomical development, air flow characterization and particle depositionIslam, MS; Paul, G; Ong, HX; Young, PM; Gu, YT; Saha, SC
2022-06Timothy Grass Pollen Induces Spatial Reorganisation of F-Actin and Loss of Junctional Integrity in Respiratory Cells.Bradbury, P; Cidem, A; Mahmodi, H; Davies, JM; Spicer, PT; Prescott, SW; Kabakova, I; Ong, HX; Traini, D
2021-07-05Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line.Sheikh, Z; Bradbury, P; Reekie, TA; Pozzoli, M; Robinson, PD; Kassiou, M; Young, PM; Ong, HX; Traini, D